GB9827102D0 - New cancer treatments - Google Patents

New cancer treatments

Info

Publication number: GB9827102D0
Authority: GB; United Kingdom
Prior art keywords: cancer treatments; new cancer; new; treatments; cancer
Prior art date: 1998-12-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9827102.6A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Onyvax Ltd

Original Assignee

Onyvax Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-10

Filing date

1998-12-10

Publication date

1999-02-03

1998-12-10 Application filed by Onyvax Ltd filed Critical Onyvax Ltd

1998-12-10 Priority to GBGB9827102.6A priority Critical patent/GB9827102D0/en

1999-02-03 Publication of GB9827102D0 publication Critical patent/GB9827102D0/en

1999-12-09 Priority to AU16696/00A priority patent/AU1669600A/en

1999-12-09 Priority to PCT/GB1999/004146 priority patent/WO2000033871A2/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/884—Vaccine for a specifically defined cancer prostate

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

GBGB9827102.6A 1998-12-10 1998-12-10 New cancer treatments Ceased GB9827102D0 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GBGB9827102.6A GB9827102D0 (en)	1998-12-10	1998-12-10	New cancer treatments
AU16696/00A AU1669600A (en)	1998-12-10	1999-12-09	New cancer treatments
PCT/GB1999/004146 WO2000033871A2 (en)	1998-12-10	1999-12-09	Use of human prostate tumour cell lines in cancer treatment

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9827102.6A GB9827102D0 (en)	1998-12-10	1998-12-10	New cancer treatments

Publications (1)

Publication Number	Publication Date
GB9827102D0 true GB9827102D0 (en)	1999-02-03

Family

ID=10843924

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9827102.6A Ceased GB9827102D0 (en)	1998-12-10	1998-12-10	New cancer treatments

Country Status (3)

Country	Link
AU (1)	AU1669600A (en)
GB (1)	GB9827102D0 (en)
WO (1)	WO2000033871A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7176022B2 (en)	2002-12-20	2007-02-13	Cell Genesys, Inc.	Directly injectable formulations which provide enhanced cryoprotection of cell products
US20050019336A1 (en) *	2003-07-23	2005-01-27	Dalgleish Angus George	Human prostate cell lines in cancer treatment
CA2536669A1 (en) *	2003-08-26	2005-03-17	Becton, Dickinson And Company	Methods for intradermal delivery of therapeutics agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2245099C (en) *	1996-02-02	2007-01-09	Suzanne L. Topalian	Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

1998
- 1998-12-10 GB GBGB9827102.6A patent/GB9827102D0/en not_active Ceased
1999
- 1999-12-09 WO PCT/GB1999/004146 patent/WO2000033871A2/en active Application Filing
- 1999-12-09 AU AU16696/00A patent/AU1669600A/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2000033871A3 (en)	2000-10-12
AU1669600A (en)	2000-06-26
WO2000033871A2 (en)	2000-06-15

Publication	Publication Date	Title
HUP0104857A3 (en)	2004-04-28	New cancer treatments
GB9804885D0 (en)	1998-04-29	Therapeutic combination
GB9800942D0 (en)	1998-03-11	Well treatment
GB9812038D0 (en)	1998-07-29	Therapeutic compound
GB9805877D0 (en)	1998-05-13	Cancer
GB9816556D0 (en)	1998-09-30	Therapy
AU1710600A (en)	2000-05-22	Enhanced radiation therapy
GB9703633D0 (en)	1997-04-09	Cancer therapy
GB9803447D0 (en)	1998-04-15	Cancer diagnosis
GB9827102D0 (en)	1999-02-03	New cancer treatments
GB9804361D0 (en)	1998-04-22	Cancer treatment
GB9819999D0 (en)	1998-11-04	Treatment of cancer
GB9903035D0 (en)	1999-03-31	Treating cancer
GB2334579B (en)	2003-06-04	Treating cancer
AU2453399A (en)	1999-08-09	Bone cancer therapy
AU4598100A (en)	2000-12-05	Treating cancer
GB9815497D0 (en)	1998-09-16	Treatment
GB9818524D0 (en)	1998-10-21	Inorgasmia treatment
GB9820000D0 (en)	1998-11-04	Cancer treatment
GB9818023D0 (en)	1998-10-14	Cancer treatment
GB9812151D0 (en)	1998-08-05	Treating cancer
GB9806039D0 (en)	1998-05-20	Therapy
GB9804050D0 (en)	1998-04-22	Cancer
GB9828550D0 (en)	1999-02-17	Treatment
GB9802420D0 (en)	1998-04-01	Skin cancer alleviator

Legal Events

Date	Code	Title	Description
2000-07-19	AT	Applications terminated before publication under section 16(1)